Jonathan J. Miner

7.9k citations

53 papers · 5.4k indexed · 5 hit papers · h-index 33

Impact in

Infectious Diseases top 0.5%
- Viral Infections and Vectors
Public Health, Environmental and Occupational Health top 0.5%
- Mosquito-borne diseases and control
- Malaria Research and Control

Papers in

Immunology 25
- interferon and immune responses 17
- Immune Response and Inflammation 5
Infectious Diseases 21
- Viral Infections and Vectors 14

Co-authors: Michael Diamond Amber M. Smith Estefanı́a Fernández Derek J. Platt Jennifer Govero Helen M. Lazear Rodger P. McEver Tadayuki Yago
Journals: Cell Reports (5 papers)Journal of Virology (4 papers)The Journal of Experimental Medicine (3 papers)Cell Host & Microbe (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Jonathan J. Miner

52 papers receiving 5.3k citations

Hit Papers

5 papers align trajectories log scale

TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells 2020 · 325 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Cell Reports
2017 Cell Host & Microbe
2017 The Lancet Infectious Diseases
2016 Cell Host & Microbe
2016 Cell

Peers

Countries citing papers authored by Jonathan J. Miner

Since Specialization

Citations

This map shows the geographic impact of Jonathan J. Miner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Miner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Miner more than expected).

Fields of papers citing papers by Jonathan J. Miner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Miner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Miner. The network helps show where Jonathan J. Miner may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan J. Miner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan J. Miner Line = papers co-authored together Jonathan J. Miner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease Brain ·Sarah McGlasson, Kayleigh M. Reid, Anna Klingseisen, Bastien Rioux, Samuel D. Chauvin, Cathrine A. Miner, Margaret Snyder, 正彦赤尾, Bethany Geary, Sophia Rodriguez, Katrina Wood, Candice Roufosse, Colin Smith, David Kavanagh, Jonathan J. Miner, David Hunt	2025	0
2	Prime Editor Gene Therapy and TREX1 Mosaicism in Retinal Vasculopathy with Cerebral Leukoencephalopathy Journal of Clinical Immunology ·Samuel D. Chauvin, Margaret Snyder, Subhajit Poddar, Cathrine A. Miner, Bernhard Berent, E Tukiainen, Jirou Kondou, Todd A. Hardy, Jonathan J. Miner	2024	2
3	Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study Journal of Clinical Investigation ·Звегинцева Екатерина Александровна, Suheir Ammar, Prethy Rao, Rennie L. Rhee, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte	2024	4
4	A path towards personalized medicine for autoinflammatory and related diseases Nature Reviews Rheumatology ·Jonathan J. Miner, Katherine A. Fitzgerald	2023	14
5	Liver pathology in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: vasculopathic disease beyond nodular regenerative hyperplasia Human Pathology ·Michael James Speerschneider, Deyali Chatterjee, W. K. L. C., M. Kathryn Liszewski, Andria L. Ford, Jonathan J. Miner, John Atkinson, Elizabeth M. Brunt	2023	2
6	Regulation of cGAS and STING signaling during inflammation and infection Journal of Biological Chemistry ·Samuel D. Chauvin, William A. Stinson, Derek J. Platt, Subhajit Poddar, Jonathan J. Miner	2023	37
7	The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice JCI Insight ·William A. Stinson, Cathrine A. Miner, Fang Zhao, Eman T. Rayes, Subhajit Poddar, Jonathan J. Miner	2022	14
8	Norovirus evolution in immunodeficient mice reveals potentiated pathogenicity via a single nucleotide change in the viral capsid PLoS Pathogens ·Forrest C. Walker, Chawengsak Khamkaen, Stefan T. Peterson, Rachel Rodgers, Lawrence A. Schriefer, 胡新丽, Yuhao Li, Gowri Kalugotla, J. R. Weske, Saja S Hashim, Broc T. McCune, Vincent R. Graziano, I‐H. Lao, Sanghyun Lee, Carpio Salas, Stephanie M. Karst, Timothy J. Nice, Jonathan J. Miner, Craig B. Wilen, Megan T. Baldridge	2021	12
9	TBK1 and IKK epsilon Act Redundantly to Mediate STING-Induced NF-kappa B Responses in Myeloid Cells Cell Reports ·Katherine R. Balka, Cynthia Louis, Tahnee L. Saunders, Amber M. Smith, Dale J. Calleja, Damian B. D’Silva, Fiona Moghaddas, Maximilien Tailler, Kate E. Lawlor, Yifan Zhan, Christopher J. Burns, Ian P. Wicks, Jonathan J. Miner, Benjamin T. Kile, Seth L. Masters, Dominic De Nardo	2020	10
10	STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death The Journal of Experimental Medicine ·Jianjun Wu, Yu‐Ju Chen, Nicole Dobbs, Tomomi Sakai, Jen Liou, Jonathan J. Miner, Nan Yan	2019	233
11	Protective and Pathogenic Effects of Interferon Signaling During Pregnancy Viral Immunology ·Xia Chai, Helen M. Lazear, Jonathan J. Miner	2019	40
12	Tofacitinib for refractory uveitis and scleritis American Journal of Ophthalmology Case Reports ·Michael Paley, Hümeyra Karacal, P. Kumar Rao, Todd P. Margolis, Jonathan J. Miner	2018	84
13	Consequences of congenital Zika virus infection Current Opinion in Virology ·Derek J. Platt, Jonathan J. Miner	2017	31
14	Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen The Lancet Infectious Diseases ·Felicity J. Burt, Weiqiang Chen, Jonathan J. Miner, Deborah J. Lenschow, Andres Merits, Esther Schnettler, Alain Kohl, Penny A. Rudd, Adam Taylor, Lara J. Herrero, Ali Zaid, Lisa F. P. Ng, Suresh Mahalingam Hit paper breakdown →	2017	306
15	A Mouse Model of Zika Virus Pathogenesis Cell Host & Microbe ·Helen M. Lazear, Jennifer Govero, Amber M. Smith, Derek J. Platt, Estefanı́a Fernández, Jonathan J. Miner, Michael Diamond Hit paper breakdown →	2016	698
16	AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity eLife ·Edward T. Schmid, Iris K. Pang, Eugenio Antonio Carrera Silva, Lidia Bosurgi, Jonathan J. Miner, Michael Diamond, Akiko Iwasaki, Carla V. Rothlin	2016	47
17	Cardiac Manifestations of Systemic Lupus Erythematosus Rheumatic Disease Clinics of North America ·Jonathan J. Miner, Alfred H.J. Kim	2013	117
18	Differential regulation of human and murine P-selectin expression and function in vivo The Journal of Experimental Medicine ·Zhenghui Liu, Jonathan J. Miner, Tadayuki Yago, Longbiao Yao, Florea Lupu, Lijun Xia, Rodger P. McEver	2010	65
19	Core 1-derived O-glycans are essential E-selectin ligands on neutrophils Proceedings of the National Academy of Sciences ·Tadayuki Yago, Jianxin Fu, J. Michael McDaniel, Jonathan J. Miner, Rodger P. McEver, Lijun Xia	2010	63
20	Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report BMC Gastroenterology ·Jonathan J. Miner, Gwen Bradford, Philip Alex, Michael Centola	2005	3

About Jonathan J. Miner

Jonathan J. Miner is a scholar working on Immunology, Infectious Diseases, Immunology and Allergy, Ophthalmology and Business and International Management, having authored 53 papers that have together received 5.4k indexed citations. Recurring topics across this work include interferon and immune responses (17 papers), Viral Infections and Vectors (14 papers), Mosquito-borne diseases and control (14 papers), Inflammasome and immune disorders (9 papers), Systemic Lupus Erythematosus Research (5 papers), Ocular Diseases and Behçet’s Syndrome (5 papers), Immune Response and Inflammation (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), Public Health, Environmental and Occupational Health (2.6k citations), Immunology (1.7k citations), Immunology and Allergy (295 citations) and Virology (153 citations). Jonathan J. Miner has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Michael Diamond, Amber M. Smith, Estefanı́a Fernández, Derek J. Platt, Jennifer Govero, Helen M. Lazear, Rodger P. McEver, Tadayuki Yago, Alfred H.J. Kim and Kazuma Noguchi. Their work appears in journals such as Cell Reports, Journal of Virology, The Journal of Experimental Medicine, Cell Host & Microbe and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact